Vora J P, Hendre T J, Atiea J, Owens D R
Department of Medicine, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Diabetes Res. 1989 May;11(1):9-12.
Effective renal plasma flow (RPF) and glomerular filtration rate (GFR) were assessed in early insulin dependent diabetics (duration of diabetes less than 10 yr) during short term administration of angiotensin converting enzyme inhibitor. In a double blind randomized study, RPF and GFR were measured in normotensive normoalbuminuric (albumin excretion rate less than 20 micrograms/min) male IDDs before and after two weeks of Captopril 25 mg bd (n = 6) or placebo (n = 6). RPF and GFR were measured by means of a primed constant infusion of 125I iodohippurate and 51CR EDTA, respectively and corrected for 1.73m2 surface area. Supine blood pressure was measured throughout the study period. Mean (+/- SE) systolic and diastolic blood pressures were unchanged in both groups of subjects, being 124 +/- 5 mmHg and 78 +/- 4 mmHg before and 126 +/- 5 mm and 81 +/- 4 mm during Captopril and 121 +/- 6 mm and 79 +/- 4 mm before and 120 +/- 5 mm and 80 +/- 3 mm during placebo administration. RPF and GFR remained unchanged during Captopril administration, from 719 +/- 28 ml/min and 148 +/- 6 ml/min prior to and 721 +/- 26 ml/min and 149 +/- 6 ml/min during therapy. Similarly RPF and GFR were unchanged in the placebo treated group at 634 +/- 24 ml/min and 143 +/- 5 ml/min before end 630 +/- 28 ml/min and 140 +/- 7 ml/min after two weeks. Glycaemic control was unchanged in either group during the study period.(ABSTRACT TRUNCATED AT 250 WORDS)
在早期胰岛素依赖型糖尿病患者(糖尿病病程小于10年)短期服用血管紧张素转换酶抑制剂期间,评估了有效肾血浆流量(RPF)和肾小球滤过率(GFR)。在一项双盲随机研究中,对血压正常、尿白蛋白正常(白蛋白排泄率小于20微克/分钟)的男性胰岛素依赖型糖尿病患者(IDDs),在服用25毫克卡托普利每日两次(n = 6)或安慰剂(n = 6)两周前后,分别测量RPF和GFR。RPF和GFR分别通过静脉注射125I碘马尿酸盐和51Cr乙二胺四乙酸(EDTA)的方法进行测量,并根据1.73平方米的体表面积进行校正。在整个研究期间测量仰卧位血压。两组受试者的平均(±标准误)收缩压和舒张压均无变化,服用卡托普利前为124±5毫米汞柱和78±4毫米汞柱,服用期间为126±5毫米汞柱和81±4毫米汞柱;服用安慰剂前为121±6毫米汞柱和79±4毫米汞柱,服用期间为120±5毫米汞柱和80±3毫米汞柱。在服用卡托普利期间,RPF和GFR保持不变,治疗前为719±28毫升/分钟和148±6毫升/分钟,治疗期间为721±26毫升/分钟和149±6毫升/分钟。同样,安慰剂治疗组的RPF和GFR也没有变化,治疗前为634±24毫升/分钟和143±5毫升/分钟,两周后为630±28毫升/分钟和140±7毫升/分钟。在研究期间,两组的血糖控制均未改变。(摘要截选至250字)